Trademark: 79362259
Word
XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT
Status
Registered
Status Code
700
Status Date
Tuesday, March 26, 2024
Serial Number
79362259
Registration Number
7334071
Registration Date
Tuesday, March 26, 2024
Mark Type
3000
Filing Date
Monday, May 23, 2022
Published for Opposition
Tuesday, January 9, 2024

Trademark Owner History
Vetter Pharma-Fertigung GmbH & Co. KG - Original Registrant
Rentschler Biopharma SE - Original Registrant

Classifications
40 Contract manufacturing in the field of pharmaceuticals and pharmaceutical substances; custom manufacture of veterinary preparations and substances; custom manufacture of diagnostic preparations and substances for medical and veterinary use; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; consultancy services relating to custom manufacturing process services; assembly of products for others, custom manufacture and assembly services, custom assembly for others of electronic components for medical devices and apparatus, semiconductor components and circuit switches; consultancy and information for the customised manufacture and production processes for electronic components, semi-conductor components and circuits for medical apparatus and equipment
39 Bottling services and storage of goods in the nature of liquid and solid substances, especially, pharmaceuticals, medicines and solutions, for others
44 Medical services; medical assistance; animal healthcare services, namely, animal breeding, animal grooming, medical analysis services for diagnostic and treatment purposes; consultancy and information services relating to biopharmaceutical products, namely, providing medical information and pharmaceutical consultation in the nature of a medical consultation relating to biopharmaceutical products
42 Scientific and technological services, namely, scientific research, analysis, testing and development in the field of biomanufacturing and in the pharmaceutical field and research and design relating thereto; industrial analysis and research services, namely, chemical, biochemical, biological and bacteriological research and analysis and industrial research in the field of pharmaceuticals; chemistry services, namely, chemistry consultation, research in the fields of chemistry; biochemical services, namely, biochemistry consultation, research in the fields of biochemistry; services of medical, bacteriological and chemical laboratories, namely, laboratory research and laboratory analysis; research on the subject of pharmaceuticals; biochemistry research services; development of pharmaceutical, veterinary and diagnostic products and substances and methods for the manufacture thereof, in particular using biotechnological and genetically-engineered means, in the nature of research in the field of manufacturing machinery for pharmaceutical, veterinary and diagnostic products and substances, design and development of computer hardware for the pharmaceutical, veterinary and diagnostic products and substances manufacturing industries; technological consultancy relating to pharmacy, namely, consulting services in the field of pharmaceutical research and development, technical consulting in the field of pharmaceutical studies; technological consultancy in the veterinary research field; technological consultancy in the field of diagnostics, namely, consulting services in the field of pharmaceutical research and development, consulting services in the field of pharmacogenetics; quality control for others; providing information and data relating to medical research and development; development of syringes and instruments for injections, injectors and packaging for the aforesaid goods for others; product quality and product safety testing, namely, chemical testing, physical testing and process engineering testing, in particular laboratory testing; pharmacological and microbiological development, research and analysis for others; conducting clinical tests, namely, scientific research in the nature of conducting clinical trials for others; conducting technical project studies in the nature of scientific feasibility studies and technological support services being technological research in the field of pharmaceutical agent manufacturing processes and pharmaceutical co-filling and packaging processes; industrial manufacturing process development consultancy
The mark consists of the stacked wording "XPERT ALLIANCE" in blue. To the right of the term "XPERT" appears the wording "RENTSCHLER" in orange above the wording "& VETTER" in orange. All the aforesaid appears above the wording "SUBSTANCE PRODUCT PATIENT" in black with these terms separated by orange triangles.
EXPERT ALLIANCE RENTSCHLER AND VETTER SUBSTANCE PRODUCT PATIENT
The color(s) black, blue, and orange is/are claimed as a feature of the mark.
"EXPERT ALLIANCE"

Trademark Events
Mar 26, 2024
Notice Of Registration Confirmation Emailed
Mar 26, 2024
Registered-Principal Register
Jan 9, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 9, 2024
Published For Opposition
Jan 8, 2024
Notification Processed By Ib
Dec 20, 2023
Notification Of Possible Opposition Sent To Ib
Dec 20, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 20, 2023
Notification Of Notice Of Publication E-Mailed
Dec 5, 2023
Approved For Pub - Principal Register
Dec 5, 2023
Examiner's Amendment Entered
Dec 5, 2023
Notification Of Examiners Amendment E-Mailed
Dec 5, 2023
Examiners Amendment E-Mailed
Dec 5, 2023
Examiners Amendment -Written
Nov 9, 2023
Teas/Email Correspondence Entered
Nov 9, 2023
Correspondence Received In Law Office
Nov 9, 2023
Teas Response To Office Action Received
Jun 7, 2023
Refusal Processed By Ib
May 12, 2023
Non-Final Action Mailed - Refusal Sent To Ib
May 11, 2023
Refusal Processed By Mpu
Mar 22, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Mar 21, 2023
Non-Final Action Written
Mar 11, 2023
Assigned To Examiner
Feb 14, 2023
Application Filing Receipt Mailed
Feb 10, 2023
New Application Office Supplied Data Entered
Feb 9, 2023
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24